Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
Other Sizes |
|
Purity: ≥98%
Temafloxacin (Omniflox) is a potent fluoroquinolone antibiotic and antimycobacterial agent that acts as a DNA topoisomerase inhibitor. It has broad antimicrobial activity against gram-positive and gram-negative bacteria, such as S. pneumoniae, M. hominis, and anaerobic bacteria, including B. fragilis. It was approved in 1992 for the treatment of lower respiratory tract infections, genital and urinary infections like prostatitis, and skin infections, but was withdrawn from sale in the United States shortly after its approval in 1992 because of serious adverse effects resulting in three deaths.
Targets |
Quinolone
|
---|---|
ln Vitro |
Temafloxacin (0-64 µg/mL; 18–24 h) exhibits good antibacterial activity against gram-positive and gram-negative bacteria, with MIC ranges for E. Coli, P. aeruginosa, and S. aureus, respectively, of <0.004-0.5, 0.5-2, and 0.06-0.25 µg/mL[1].
|
ln Vivo |
Temafloxacin (6.25, 25, 100 mg/kg; p.o. ; single dose) exhibits good anti-mouse pyelonephritis activity[1].
With the exception of the central nervous system (CNS), temafloxacin hydrochloride (100 mg/kg; p.o. or s.c.; single) exhibits rapid gastrointestinal absorption and excellent tissue and body fluid penetration and concentration[1]. |
Cell Assay |
Cell Line: E. coli (16 strains), P. aeruginosa (13 strains), and S. aureus (17 strains).
Concentration: 0-64 µg/mL Incubation Time: 18-24 h Result: MIC ranges of <0.004-0.5 (MIC 90%=0.06, =0.06), 0.5-2 (MIC 90%=1, MIC 50%=1), and 0.06-0.25 µg/mL (MIC 90%=0.125, MIC 50%=0.125) inhibited 16 strains of E. coli, P. aeruginosa, and S. aureus. 90% and 50% of the isolates are included in the MIC (unit: µg/mL). |
Animal Protocol |
Animal Model: Female CF-1 mice (20-25 g) (murine pyelonephritis model)[1].
Dosage: 6.25, 25, 100 mg/kg Administration: Orally; single. Result: Reduced the number of viable bacteria in the kidneys of mice. |
References |
Molecular Formula |
C21H18F3N3O3
|
---|---|
Molecular Weight |
417.39
|
Exact Mass |
417.13
|
Elemental Analysis |
C, 60.43; H, 4.35; F, 13.66; N, 10.07; O, 11.50
|
CAS # |
108319-06-8
|
Related CAS # |
Temafloxacin hydrochloride;105784-61-0
|
Appearance |
Solid powder
|
SMILES |
O=C(C1=CN(C2=CC=C(F)C=C2F)C3=C(C=C(F)C(N4CC(C)NCC4)=C3)C1=O)O
|
InChi Key |
QKDHBVNJCZBTMR-UHFFFAOYSA-N
|
InChi Code |
InChI=1S/C21H18F3N3O3/c1-11-9-26(5-4-25-11)19-8-18-13(7-16(19)24)20(28)14(21(29)30)10-27(18)17-3-2-12(22)6-15(17)23/h2-3,6-8,10-11,25H,4-5,9H2,1H3,(H,29,30)
|
Chemical Name |
1-(2,4-Difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
|
Synonyms |
trade name: Omniflox; A-62254; A62254; A 62254
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : < 1 mg/mL
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 0.5 mg/mL (1.20 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 2: 10% DMSO+90% Corn Oil: ≥ 0.5 mg/mL (1.20 mM)  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.3958 mL | 11.9792 mL | 23.9584 mL | |
5 mM | 0.4792 mL | 2.3958 mL | 4.7917 mL | |
10 mM | 0.2396 mL | 1.1979 mL | 2.3958 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.